A COMPARISION OF DELTA-9-TETRAHYDROCANNABINOL DEPENDENCE IN C57Bl/6j MICE AND FATTY ACID AMIDE HYDROLASE KNOCK OUT MICE

A COMPARISION OF DELTA-9-TETRAHYDROCANNABINOL DEPENDENCE IN C57Bl/6j MICE AND FATTY ACID AMIDE HYDROLASE KNOCK OUT MICE

The idea that humans and laboratory animals can become physically dependent on marijuana or its primary psychoactive constituent, delta-9-tetrahydrocannabinol (THC), is gaining acceptance. However, there are no currently approved pharmacotherapies to treat cannabinoid withdrawal. The objective of...

Full description

Bibliographic Details
Main Author:	Carlson, Brittany Leigh Alice
Format:	Others
Published:	VCU Scholars Compass 2007
Subjects:	marijuana psychoactive cannabinoid THC withdrawal physical dependence G protein Medical Pharmacology Medical Sciences Medicine and Health Sciences
Online Access:	http://scholarscompass.vcu.edu/etd/686 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=1685&context=etd

Similar Items

Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey
by: Jamie Corroon, et al.
Published: (2019-12-01)

Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
by: Jerome Sarris, et al.
Published: (2020-01-01)

Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
by: Eric P. Baron, et al.
Published: (2018-05-01)

PSYCHOACTIVE SUBSTANCES ABUSE TRENDS AMONG MEDICAL STUDENTS OF LAHORE; A CROSS SECTIONAL STUDY
by: Maryam Noshad, et al.
Published: (2020-12-01)

Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
by: Joshua D. Brown
Published: (2020-03-01)

Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants
by: Káthia M. Honório, et al.
Published: (2013-10-01)

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review
by: Copel, et al.
Published: (2016-05-01)

EFFECTS OF ACUTE THC ADMINISTRATION ON EXTINCTION OF CONDITIONED FEAR RESPONSES IN HUMANS: A FUNCTIONAL ANALYSIS OF HIGH DENSITY EEG
by: Diggs, Herman Augustus
Published: (2014)

Acute effects of Delta-9-Tetrahydrocannabinol on performance monitoring in healthy volunteers
by: Desiree eSpronk, et al.
Published: (2011-09-01)

Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry
by: Joshua D. Brown, et al.
Published: (2020-04-01)

The emergency department care of the cannabis and synthetic cannabinoid patient: a narrative review
by: Kevin M. Takakuwa, et al.
Published: (2021-02-01)

Marijuana use in U.S. teen drivers: a comparison of a road-side survey of reported use and fluid tests for tetrahydrocannabinol (THC)
by: Joyce C. Pressley, et al.
Published: (2019-05-01)

Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function
by: Staci A Gruber, et al.
Published: (2016-10-01)

Cannabis-based medicines and the perioperative physician
by: Patrick Tapley, et al.
Published: (2019-12-01)

Cannabinoid Modulation of Reinforcement Maintained by Stimulation of the Medial Forebrain Bundle in C57Bl/6J Mice
by: Wiebelhaus, Jason
Published: (2013)

Marijuana intoxication in a cat
by: Agnieszka Janeczek, et al.
Published: (2018-07-01)

Acute Cannabinoids Produce Robust Anxiety-Like and Locomotor Effects in Mice, but Long-Term Consequences Are Age- and Sex-Dependent
by: Chelsea R. Kasten, et al.
Published: (2019-02-01)

Cannabis Extract CT-921 Has a High Efficacy–Adverse Effect Profile in a Neuropathic Pain Model
by: Rouhollahi E, et al.
Published: (2020-08-01)

A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis
by: Wilsey BL, et al.
Published: (2016-08-01)

Epigenetic Mediation of <i>AKT1</i> rs1130233’s Effect on Delta-9-Tetrahydrocannabinol-Induced Medial Temporal Function during Fear Processing
by: Grace Blest-Hopley, et al.
Published: (2021-09-01)

Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma
by: Clara Andradas, et al.
Published: (2021-01-01)

The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology
by: Clara Andradas, et al.
Published: (2021-01-01)

Children and Youth Who Use Cannabis for Pain Relief: Benefits, Risks, and Perceptions
by: Woo JJ, et al.
Published: (2020-05-01)

Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?
by: Nancy De Briyne, et al.
Published: (2021-03-01)

A content analysis of internet information sources on medical cannabis
by: Daniel J. Kruger, et al.
Published: (2020-09-01)

Cannabinoids cases in polish athletes
by: A Pokrywka, et al.
Published: (2009-07-01)

A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019
by: Sebastian Jugl, et al.
Published: (2021-02-01)

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
by: Lourdes Poyatos, et al.
Published: (2020-06-01)

The Effect of Cannabis-Based Medicine on Neuropathic Pain and Spasticity in Patients with Multiple Sclerosis and Spinal Cord Injury: Study Protocol of a National Multicenter Double-Blinded, Placebo-Controlled Trial
by: Julie Schjødtz Hansen, et al.
Published: (2021-09-01)

The Impact of THC and CBD in Schizophrenia: A Systematic Review
by: Saeed Ahmed, et al.
Published: (2021-07-01)

Do Cannabis Users Reduce Their THC Dosages When Using More Potent Cannabis Products? A Review
by: Janni Leung, et al.
Published: (2021-02-01)

Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
by: Mina G. Nashed, et al.
Published: (2021-01-01)

EFFECTS OF ACUTE THC ADMINISTRATION ON EXTINCTION OF CONDITIONED FEAR RESPONSES IN HUMANS
by: Diggs, Herman Augustus
Published: (2010)

Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews
by: Nadia Montero-Oleas, et al.
Published: (2020-01-01)

Differential effects of endocannabinoid catabolic inhibitors on opioid withdrawal in mice
by: Gamage, Thomas
Published: (2013)

Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction
by: Xinwen Chang, et al.
Published: (2017-06-01)

Determination of the Rewarding Capacity of Edible and Injected Delta-9-Tetrahydrocannabinol in Adolescent and Adult Mice
by: Smoker, Michael P.
Published: (2020)

Cannabinoids from Cannabis sp.: mechanism of their activity and potential health benefits in human body
by: Grzegorz Dąbrowski, et al.
Published: (2017-08-01)

Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a synthetic cannabinoid (SCB)
by: Priyanka Parajuli, et al.
Published: (2020-07-01)

Reversing the Psychiatric Effects of Neurodevelopmental Cannabinoid Exposure: Exploring Pharmacotherapeutic Interventions for Symptom Improvement
by: Marta De Felice, et al.
Published: (2021-07-01)